UnisLink Appoints Julie Klapstein and Christine Schuster to Board of Directors
New board members provide depth in technology-enabled healthcare services, revenue cycle management, and clinical practice PHOENIX, Jan. 9, 2025 /PRNewswire/...
Veterans
AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of...
Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid’s Emerging Role in Renal Replacement Therapy Decisions
Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac...
Now Open: VITAS® Healthcare Inpatient Hospice Unit in Fort Worth
Freestanding homelike facility for specialized end-of-life care will serve 500+ patients annuallyFORT WORTH, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) --...
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
Phase 2 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of cutaneous venous malformations...
Allied OMS Continues Strategic Expansion in Texas with Parkway Oral Surgery in Houston
SOUTHLAKE, TX and HOUSTON, TX / ACCESSWIRE / January 7, 2025 / Allied OMS, one of the country's premier management...
Quantum Biopharma Ltd. Approved to Dual List on Upstream
Trading to become available January 14th under 'QNTM' TORONTO, ONTARIO / ACCESSWIRE / January 7, 2025 / Quantum BioPharma Ltd....
Walgreens and Visory Health Ink New Deal
Walgreens’ nine million daily shoppers now have access to discounted medication through Visory Health as one of Visory Health’s Featured...
Veterans Benefits Administration awards medical disability examination services contract to Leidos QTC Health Services
RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the...
PharmaTher CEO Issues Letter to Shareholders
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty...
ZetrOZ Systems Presents sam(R) Technology to Leaders in Military and Professional Sports Healthcare
The creators of sustained acoustic medicine and the sam® wearable ultrasound unit connected with key user bases in military orthopedic...
WEED Inc. President and CEO Releases Letter to Shareholders
TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a...
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global...
CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024 /PRNewswire/ -- Caresyntax, the leading...
Quantum Biopharma Announces Closing of Second Tranche
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased...
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased...
Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications
Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially ADHD or other neuropsychiatric indicationsThe import was conducted...
Alumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005
– A-005 was well tolerated and demonstrated ability to cross blood-brain barrier – – Maximal TYK2 inhibition achieved with favorable...
Aspirion Expands Revenue Cycle Management Capabilities Through Strategic Acquisition of Boost Healthcare
COLUMBUS, Ga., Dec. 18, 2024 /PRNewswire/ -- Aspirion, the healthcare technology revenue cycle management ("RCM") leader for denials, payment variance,...
Neutrolis Expands Senior Leadership Team to Drive Development of Growing Pipeline of Non-Immunosuppressive Therapies for NET-mediated Autoimmune Diseases
Appointment of seasoned executives with substantial industry expertise strengthens team as the company advances programs into the clinicCAMBRIDGE, Mass., Dec....